4-Aminobutyrate Aminotransferase (ABAT) Peptide
ABAT
适用: 哺乳动物
宿主: 合成
BP, WB, IHC
-
- 抗原 See all ABAT products
- ABAT (4-Aminobutyrate Aminotransferase (ABAT))
- 蛋白类型
- Synthetic
- 宿主
- 哺乳动物
-
资源
- 合成
- 应用范围
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- 序列
- IIVEPIQSEG GDNHASDDFF RKLRDIARKH GCAFLVDEVQ TGGGCTGKFW
- 产品特性
-
A synthetic peptide for use as a blocking control in assays to test for specificity of ABAT antibody,
Alternative Names: ABAT control peptide, ABAT antibody Blocking Peptide, Anti-ABAT Blocking Peptide, 4-Aminobutyrate Aminotransferase Blocking Peptide, GABA-AT Blocking Peptide, GABAT Blocking Peptide, NPD009 Blocking Peptide
-
-
- 应用备注
- Optimal conditions should be determined by the investigator
- 限制
- 仅限研究用
-
- 状态
- Lyophilized
- 溶解方式
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- 缓冲液
- PBS
- 注意事项
- Avoid repeated freeze/thaw cycles.
- 储存条件
- -20 °C
- 储存方法
- Store at -20 °C long term.
-
- 抗原
- ABAT (4-Aminobutyrate Aminotransferase (ABAT))
- 背景
- 4-aminobutyrate aminotransferase (ABAT) is responsible for catabolism of gamma-aminobutyric acid (GABA), an important, mostly inhibitory neurotransmitter in the central nervous system, into succinic semialdehyde. The active enzyme is a homodimer of 50 kDa subunits complexed to pyridoxal-5-phosphate. ABAT in liver and brain is controlled by 2 codominant alleles with a frequency in a Caucasian population of 0.56 and 0.44. The ABAT deficiency phenotype includes psychomotor retardation, hypotonia, hyperreflexia, lethargy, refractory seizures, and EEG abnormalities.4-aminobutyrate aminotransferase (ABAT) is responsible for catabolism of gamma-aminobutyric acid (GABA), an important, mostly inhibitory neurotransmitter in the central nervous system, into succinic semialdehyde.
- 分子量
- 55 kDa
-
You are here:
